Symrise AG (ETR:SY1)
Germany
· Delayed Price · Currency is EUR 105.05
+1.05 (1.01%)
May 30, 2025, 5:35 PM CET
Symrise AG Revenue
In the year 2024, Symrise AG had annual revenue of 5.00B EUR with 5.67% growth. Symrise AG had revenue of 2.43B in the half year ending December 31, 2024, with 3.18% growth.
Revenue
5.00B
Revenue Growth
+5.67%
P/S Ratio
2.91
Revenue / Employee
394.48K
Employees
12,956
Market Cap
14.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.00B | 268.33M | 5.67% |
| Dec 31, 2023 | 4.73B | 111.71M | 2.42% |
| Dec 31, 2022 | 4.62B | 792.79M | 20.72% |
| Dec 31, 2021 | 3.83B | 305.24M | 8.67% |
| Dec 31, 2020 | 3.52B | 112.60M | 3.30% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BASF SE | 65.11B |
| Heidelberg Materials AG | 21.25B |
| Covestro AG | 14.15B |
| Evonik Industries AG | 15.14B |
| Brenntag SE | 16.31B |
| Wacker Chemie AG | 5.71B |
| K+S Aktiengesellschaft | 3.63B |
| LANXESS Aktiengesellschaft | 6.36B |
Symrise AG News
- 4 weeks ago - EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 4 weeks ago - Symrise Shines: Strong Q1 Growth & Steady Outlook - Wallstreet:Online
- 4 weeks ago - EQS-News: Symrise delivers solid growth in Q1 and reaffirms outlook - Wallstreet:Online
- 2 months ago - EQS-PVR: Symrise AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - EQS-News: Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC - Wallstreet:Online
- 3 months ago - Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP - GlobeNewsWire
- 3 months ago - EQS-DD: Symrise AG: Dr. Stephanie Coßmann, buy - Wallstreet:Online
- 4 months ago - EQS-DD: Symrise AG: Olaf Klinger, buy - Wallstreet:Online